Ryan J. Watts - Net Worth and Insider Trading
Ryan J. Watts Net Worth
The estimated net worth of Ryan J. Watts is at least $66 Million dollars as of 2024-11-05. Ryan J. Watts is the President and CEO of Denali Therapeutics Inc and owns about 2,438,411 shares of Denali Therapeutics Inc (DNLI) stock worth over $66 Million. Details can be seen in Ryan J. Watts's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ryan J. Watts has not made any transactions after 2024-10-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ryan J. Watts
Ryan J. Watts Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ryan J. Watts owns 1 companies in total, including Denali Therapeutics Inc (DNLI) .
Click here to see the complete history of Ryan J. Watts’s form 4 insider trades.
Insider Ownership Summary of Ryan J. Watts
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
DNLI | Denali Therapeutics Inc | 2024-10-18 | director & President and CEO |
Ryan J. Watts Latest Holdings Summary
Ryan J. Watts currently owns a total of 1 stock. Ryan J. Watts owns 2,438,411 shares of Denali Therapeutics Inc (DNLI) as of October 18, 2024, with a value of $66 Million.
Latest Holdings of Ryan J. Watts
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
DNLI | Denali Therapeutics Inc | 2024-10-18 | 2,438,411 | 27.21 | 66,349,163 |
Holding Weightings of Ryan J. Watts
Ryan J. Watts Form 4 Trading Tracker
According to the SEC Form 4 filings, Ryan J. Watts has made a total of 31 transactions in Denali Therapeutics Inc (DNLI) over the past 5 years, including 0 buys and 31 sells. The most-recent trade in Denali Therapeutics Inc is the sale of 40,000 shares on October 18, 2024, which brought Ryan J. Watts around $1 Million.
Insider Trading History of Ryan J. Watts
- 1
Ryan J. Watts Trading Performance
Ryan J. Watts Ownership Network
Ownership Network List of Ryan J. Watts
Ownership Network Relation of Ryan J. Watts
Ryan J. Watts Owned Company Details
What does Denali Therapeutics Inc do?
Who are the key executives at Denali Therapeutics Inc?
Ryan J. Watts is the director & President and CEO of Denali Therapeutics Inc. Other key executives at Denali Therapeutics Inc include CFO and Treasurer Steve E. Krognes , COO and Secretary Alexander O. Schuth , and Chief Medical Officer Carole Ho .
Denali Therapeutics Inc (DNLI) Insider Trades Summary
Over the past 18 months, Ryan J. Watts made 8 insider transaction in Denali Therapeutics Inc (DNLI) with a net sale of 131,985. Other recent insider transactions involving Denali Therapeutics Inc (DNLI) include a net sale of 25,506 shares made by Vicki L Sato , a net sale of 83,768 shares made by Alexander O. Schuth , and a net sale of 54,249 shares made by Carole Ho .
In summary, during the past 3 months, insiders sold 113,507 shares of Denali Therapeutics Inc (DNLI) in total and bought 0 shares, with a net sale of 113,507 shares. During the past 18 months, 459,258 shares of Denali Therapeutics Inc (DNLI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 459,258 shares.
Denali Therapeutics Inc (DNLI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Denali Therapeutics Inc Insider Transactions
Ryan J. Watts Mailing Address
Above is the net worth, insider trading, and ownership report for Ryan J. Watts. You might contact Ryan J. Watts via mailing address: C/o Denali Therapeutics Inc., 151 Oyster Point Blvd., 2nd Floor, South San Francisco Ca 94080.